Steven N. Goodman

Steven N Goodman
Citizenship American
Fields Medical Research, Epidemiology, Medical Statistics
Education AB, Harvard College, Biochemistry, Applied Math (1976)
Alma mater Harvard University
New York University;
Thesis  (1989)
Known for "Cancer research: Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents". 

Steven N. Goodman is an American Professor of Medicine and of Health Research and Policy (Epidemiology) at Stanford School of Medicine.[1] He has extensively contributed to statistics and probability analysis within the biosciences, and in 1999 he coined the term "p-value fallacy".[2]

Life

He graduated with an AB (Bachelor of Arts) in Biochemistry and Applied Math from Harvard College in 1976. He received an MD from New York University in 1981, qualified as a Pediatrician in 1985, received an MHS, Biostatistics (1987) and a PhD (1989) Epidemiology from Johns Hopkins School of Public Health.

Co-director, along with John Ioannidis, of the Meta-Research Innovation Center at Stanford (METRICS).

Awards

Works

He has made numerous contributions to meta analysis.[3][4][5][6][7][8][9][10][11][12][13][14] in addition to works on scientific evidence.[15][16][17][18][19][20][21][22][23][24][25][26][27][28]

References

  1. ↑ "Steven Goodman".
  2. ↑ Sellke, Thomas; Bayarri, M. J; Berger, James O (February 2001). "Calibration of ρ Values for Testing Precise Null Hypotheses". The American Statistician 55 (1): 62–71. doi:10.1198/000313001300339950.
  3. ↑ Cornell, J. E., Mulrow, C. D., Localio, R., Stack, C. B., Meibohm, A. R., Guallar, E., Goodman, S. N. (2014). "Random-Effects Meta-analysis of Inconsistent Effects: A Time for Change.". Annals of Internal Medicine 160 (4): 267–270. doi:10.7326/M13-2886.
  4. ↑ Basch, E., Aronson, N., Berg, A., Flum, D., Gabriel, S., Goodman, S. N., Helfand, M., Ioannidis, J. P., Lauer, M., Meltzer, D., Mittman, B., Newhouse, R., Normand, S., Schneeweiss, S., Slutsky, J., Tinetti, M., Yancy, C. (2012). "Methodological Standards and Patient-Centeredness in Comparative Effectiveness Research The PCORI Perspective". JAMA 307 (15): 1636–1640. doi:10.1001/jama.2012.466.
  5. ↑ Goodman, S. N. (2012). "Quasi-random reflections on randomized controlled trials and comparative effectiveness research". Clinical Trials 9 (1): 22–26. doi:10.1177/1740774511433285.
  6. ↑ Sox, H. C., Goodman, S. N. (2012). "The Methods of Comparative Effectiveness Research". Annual Review of Public Health 33: 425–445. doi:10.1146/annurev-publhealth-031811-124610.
  7. ↑ Goodman, S., Dickersin, K. (2011). "Metabias: A Challenge for Comparative Effectiveness Research". Annals of Internal Medicine 155 (1): 61-U104. doi:10.1059/0003-4819-155-1-201107050-00010.
  8. ↑ Luce, B. R., Kramer, J. M., Goodman, S. N., Connor, J. T., Tunis, S., Whicher, D., Schwartz, J. S. (2009). "Rethinking Randomized Clinical Trials for Comparative Effectiveness Research: The Need for Transformational Change". Annals of Internal Medicine 151 (3): 206-W45. doi:10.7326/0003-4819-151-3-200908040-00126.
  9. ↑ Goodman SN, Greenland S (2007). "Assessing the unreliability of the medical literature: A response to "Why most published research findings are false"".
  10. ↑ Goodman, S. N. (2002). "The mammography dilemma: A crisis for evidence-based medicine?". Annals of Internal Medicine 137 (5): 363–365. doi:10.7326/0003-4819-137-5_part_1-200209030-00015.
  11. ↑ Goodman, S. N., Zahurak, M. L., PIANTADOSI, S. (1995). "SOME PRACTICAL IMPROVEMENTS IN THE CONTINUAL REASSESSMENT METHOD FOR PHASE-I STUDIES". Statistics in Medicine 14 (11): 1149–1161. doi:10.1002/sim.4780141102.
  12. ↑ Goodman, S. N., Berlin, J. A. (1994). "THE USE OF PREDICTED CONFIDENCE-INTERVALS WHEN PLANNING EXPERIMENTS AND THE MISUSE OF POWER WHEN INTERPRETING RESULTS". Annals of Internal Medicine 121 (3): 200–206. doi:10.7326/0003-4819-121-3-199408010-00008.
  13. ↑ Goodman, S. N. (1989). "META-ANALYSIS AND EVIDENCE". Controlled Clinical Trials 10 (2): 188–204. doi:10.1016/0197-2456(89)90030-5.
  14. ↑ Goodman, S. N., Royall, R. (1988). "EVIDENCE AND SCIENTIFIC-RESEARCH". American Journal of Public Health 78 (12): 1568–1574. doi:10.2105/ajph.78.12.1568.
  15. ↑ Glass, T. A., Goodman, S. N., Hernán, M. A., Samet, J. M. (2013). "Causal inference in public health.". Annual Review of Public Health 34: 61–75. doi:10.1146/annurev-publhealth-031811-124606. PMC 4079266. PMID 23297653.
  16. ↑ Faden, R. R., Kass, N. E., Goodman, S. N., Pronovost, P., Tunis, S., Beauchamp, T. L. (2013). "An Ethics Framework for a Learning Health Care System: A Departure from Traditional Research Ethics and Clinical Ethics". Hastings Center Report 43: S16-S27. doi:10.1002/hast.134.
  17. ↑ Kass, N. E., Faden, R. R., Goodman, S. N., Pronovost, P., Tunis, S., Beauchamp, T. L. (2013). "The Research-Treatment Distinction: A Problematic Approach for Determining Which Activities Should Have Ethical Oversight". Hastings Center Report 43: S4-S15. doi:10.1002/hast.133.
  18. ↑ Mello, M. M., Goodman, S. N., Faden, R. R. (2012). "Ethical Considerations in Studying Drug Safety - The Institute of Medicine Report". New England Journal of Medicine 367 (10): 959–964. doi:10.1056/NEJMhle1207160.
  19. ↑ Goodman, S. (2011). "Confessions of a chagrined trialist". BMJ Quality & Safety 20: I97-I98. doi:10.1136/bmjqs.2010.046623.
  20. ↑ Goodman, S. N. (2007). "Stopping at nothing? Some dilemmas of data monitoring in clinical trials". Annals of Internal Medicine 146 (12): 882–887. doi:10.7326/0003-4819-146-12-200706190-00010.
  21. ↑ Laine, C., Goodman, S. N., Griswold, M. E., Sox, H. C. (2007). "Reproducible research: Moving toward research the public can really trust". Annals of Internal Medicine 146 (6): 450–453. doi:10.7326/0003-4819-146-6-200703200-00154.
  22. ↑ Goodman, S. N., Sladky, J. T. (2005). "A Bayesian approach to randomized controlled trials in children utilizing information from adults: the case of Guillain-Barre syndrome". Clinical Trials 2 (4): 305–310. doi:10.1191/1740774505cn102oa.
  23. ↑ Goodman, S. N. (2001). "Of P-values and bayes: A modest proposal". Epidemiology 12 (3): 295–297. doi:10.1097/00001648-200105000-00006.
  24. ↑ Goodman, S. N. (1999). "Toward evidence-based medical statistics. 1: The P value fallacy". Annals of Internal Medicine 130 (12): 995–1004. doi:10.7326/0003-4819-130-12-199906150-00008. PMID 10383371.
  25. ↑ Goodman, S. N. (1999). "Toward evidence-based medical statistics. 2: The Bayes factor". Annals of Internal Medicine 130 (12): 1005–1013. doi:10.7326/0003-4819-130-12-199906150-00019. PMID 10383350.
  26. ↑ Goodman, S. N., Berlin, J., Fletcher, S. W., Fletcher, R. H. (1994). "MANUSCRIPT QUALITY BEFORE AND AFTER PEER-REVIEW AND EDITING AT ANNALS OF INTERNAL-MEDICINE". Annals of Internal Medicine 121 (1): 11–21. doi:10.7326/0003-4819-121-1-199407010-00003.
  27. ↑ Goodman, S. N. (1993). "P-VALUES, HYPOTHESIS TESTS, AND LIKELIHOOD - IMPLICATIONS FOR EPIDEMIOLOGY OF A NEGLECTED HISTORICAL DEBATE". American Journal of Epidemiology 137 (5): 485–496.
  28. ↑ Goodman, S. N. (1992). "A COMMENT ON REPLICATION, P-VALUES AND EVIDENCE". Statistics in Medicine 11 (7): 875–879. doi:10.1002/sim.4780110705.
This article is issued from Wikipedia - version of the Tuesday, February 23, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.